Seqirus Vita)

Vita News & Stories from Seqirus

Vita

SHARING STORIES FROM THE FRONT LINE OF PUBLIC HEALTH

Woman engages in flu screening via a telehealth visit.

With So Many Viruses Circulating, Can You Tell Them Apart?

SARS-CoV-2 (the virus that causes COVID-19) is circulating, but so are influenza viruses and RSV. We share more information o…

08 Nov 2022
Marcus de Alwis, General Counsel, CSL Seqirus

Employee Spotlight: Marcus de Alwis

Marcus de Alwis, CSL Seqirus General Counsel, has been a part of the CSL family for over 13 years.

25 Oct 2022
D Ming, Senior Regional Account Manager for CSL Seqirus, coaching lacrosse.

Employee Spotlight: Vincent “D” Ming

Meet D, one of CSL Seqirus’ Senior Regional Account Managers by day and international lacrosse coach by night.

11 Oct 2022
OPTIONX XI Influenza Congress Logo October, 2022

What’s Top of Mind for Flu Researchers?

During last week’s OPTIONS XI conference, CSL Seqirus published articles relevant to the scientific discussions that occurred…

06 Oct 2022
Illustration of people blocking out misinformation.

Education’s Role in Fighting Infectious Diseases

Misinformation can have a profound impact on public health, experts say that education might be the key to combating it.

14 Sep 2022
Young girl receives a seasonal influenza vaccination at the doctor

Flu Fighting Tips for Back to School

School is back in session, here’s what you need to know to help keep your family protected from flu.

07 Sep 2022
Chalkboard reads

Flu is Making a Resurgence

In 2022, flu cases in Australia have spiked earlier and with more cases this season than the previous five for the same time …

30 Aug 2022
Photo of trucks at a Seqirus Facility in Melbourne, Australia.

The Art and Science of Shipping Flu Vaccines

CSL Seqirus delivered a record 135 million doses of flu vaccines globally last year, here’s how we make such a feat happen.

23 Aug 2022
Tab Lassiter, Shipping and Receiving Team Leader for CSL Seqirus.

Walk with Tab for Heart Health

Tab Lassiter – an employee of global vaccines leader CSL Seqirus – is about to receive a second transplant in an ongoing batt…

16 Aug 2022